Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Darcy R Flora, Katherine B Carlson, David C Fuehrer, Benoit Cadieux, Guy Boike, Jennifer Schenfeld & Kimberly A Lowe. (2021) Assessment of Bone Health Education in US Multiple Myeloma and Solid Tumor Patients at Risk for Skeletal-Related Events. Cancer Management and Research 13, pages 3529-3537.
Read now
Read now
Articles from other publishers (10)
Anouchka Seesaghur, Peter Egger, Joshua Warden, Ali Abbasi, Bethany Levick, Majid Riaz, Peter McMahon, Matthew Thompson & Sue Cheeseman. (2023) Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital. BMJ Open 13:5, pages e069214.
Crossref
Crossref
Darcy R. Flora, Jennifer Schenfeld, Hossam Saad, Ben Cadieux, Guy Boike & Kimberly A. Lowe. (2023) Assessment of Bone Health Awareness and Education in Breast Cancer Patients with Bone Metastasis in the USA. Journal of Cancer Education.
Crossref
Crossref
Sung-Yen Lin, Yi-Ming Chen, Wei-Ju Chen, Chun-Yi Li, Chieh-Ko Ku, Chung-Hwan Chen & Li-Nien Chien. (2022) Treatment patterns of long-dose-interval medication for persistent management of osteoporosis in Taiwan. Archives of Osteoporosis 17:1.
Crossref
Crossref
Ingo J. Diel, Richard Greil, Jan Janssen, Christian W. Kluike, Bagmeet Behera, Ali Abbasi, Anouchka Seesaghur, Michael Kellner, Christine Jaeger, Katja Bjorklof, Antoaneta Tomova & Ferdinand Haslbauer. (2022) Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study. Supportive Care in Cancer 30:11, pages 9267-9278.
Crossref
Crossref
Vanessa Wong, Richard de Boer, Catherine Dunn, Angelyn Anton, Laeeq Malik, Sally Greenberg, Belinda Yeo, Louise Nott, Ian M. Collins, Javier Torres, Frances Barnett, Michelle Nottage, Peter Gibbs & Sheau Wen Lok. (2022)
Uptake of bone‐modifying agents in patients with
HER2+
metastatic breast cancer with bone metastases – prospective data from a multi‐site Australian registry
. Internal Medicine Journal 52:10, pages 1707-1716.
Crossref
Crossref
Chin-Yao Shen, Philip Chun-Ming Au, Yeon-Hee Baek, Ching-Lung Cheung, Wei-Pang Chung, Ju Hwan Kim, Nora J. Kleinman, Tai-Chung Lam, Tzu-Chi Liao, Tzu-Chieh Lin, Ju-Young Shin, Chor-Wing Sing, Ian Chi Kei Wong & Edward Chia-Cheng Lai. (2022) Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study. BioDrugs 36:3, pages 381-392.
Crossref
Crossref
三四郎 井上. (2021) 整形外科医は骨転移を主訴とした初診時原発不明がんをどのように治療し，どのようにして原発巣の診療科に引き継いでいるのか. Orthopedics & Traumatology 70:4, pages 769-773.
Crossref
Crossref
Hirotaka Miyashita, Christina Cruz & Stephen Malamud. (2020) Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate. Breast Cancer Research and Treatment 182:2, pages 381-388.
Crossref
Crossref
Adam S. Levin. (2020) CORR Insights®: Thirty-day Postoperative Complications After Surgery for Metastatic Long Bone Disease Are Associated With Higher Mortality at 1 Year. Clinical Orthopaedics & Related Research 478:2, pages 319-321.
Crossref
Crossref
Roberta Maltoni, Michela Palleschi, Giulia Gallerani, Sara Bravaccini, Lorenzo Cecconetto, Elisabetta Melegari, Mattia Altini & Andrea Rocca. (2020) Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer. Medicine 99:24, pages e20396.
Crossref
Crossref